| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00005792-197103000-00001 |
| P698 | PubMed publication ID | 4109481 |
| P2093 | author name string | Christian CL | |
| Estes D | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | 85-95 | |
| P577 | publication date | 1971-03-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | The natural history of systemic lupus erythematosus by prospective analysis | |
| P478 | volume | 50 |
| Q34788282 | A case of systemic lupus erythematosus presenting with an acute abdomen: successful treatment with steroid |
| Q46865439 | A renal biopsy study of lupus nephropathy in the United States and Korea |
| Q41151725 | A review of glomerular ultrastructure in systemic lupus erythematosus |
| Q33556728 | A study of anti-poly (ADP-ribose) antibodies and an anti-DNA antibody idiotype and other immunological abnormalities in lupus family members |
| Q69472540 | Acute Lupus Pneumonitis: Response to Azathioprine Therapy |
| Q71397100 | Acute renal failure as the initial manifestation of systemic lupus erythematosus in children |
| Q41016280 | An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus |
| Q55357541 | Androgen-Induced Immunosuppression. |
| Q69433012 | Anorexia nervosa in a patient with systemic lupus erythematosus |
| Q33551231 | Anti-DNA antibodies in discoid lupus erythematosus. Follow-up study |
| Q41247745 | Antibodies to protein P in systemic lupus erythematosus |
| Q33450672 | Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus |
| Q52114150 | Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment. |
| Q37163113 | Antinuclear antibody-negative systemic lupus erythematosus-how common? |
| Q33603359 | Aortic regurgitation in systemic lupus erythematosus requiring aortic valve replacement |
| Q70578706 | Assessment of cognitive function in patients with systemic lupus erythematosus |
| Q33442153 | Associated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study. |
| Q35898100 | Attributing psychopathology to systemic lupus erythematosus: some methodological considerations |
| Q67599007 | Autoantibodies against cyclophilin in systemic lupus erythematosus and Lyme disease |
| Q42826821 | Autoantibody to a novel neuronal antigen in systemic lupus erythematosus and in normal human sera |
| Q55413268 | Autoimmune Diseases and Their Manifestations on Oral Cavity: Diagnosis and Clinical Management. |
| Q33630496 | Autoimmune optic neuropathy: evaluation and treatment |
| Q33551533 | Brain scan diagnosis of central nervous system involvement in systemic lupus erythematosus |
| Q34307190 | Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations |
| Q54446649 | C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. |
| Q70179457 | Can determination of lactic acid and pyruvic acid in cerebrospinal fluid help in diagnosing central nervous system involvement in systemic lupus erythematosus? |
| Q41912479 | Cardiac Tamponade in Systemic Lupus Erythematosus |
| Q34981326 | Cardiac involvement in systemic autoimmune diseases |
| Q67667944 | Central nervous system function in systemic lupus erythematosus |
| Q39831064 | Cerebral disease in systemic lupus erythematosus |
| Q36998034 | Cerebral systemic lupus erythematosus: a case report and evaluation of diagnostic tests |
| Q38237868 | Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus |
| Q33191755 | Changes in clinical features of patients with systemic lupus erythematosus followed prospectively over 2 decades |
| Q54495737 | Chlorambucil in the treatment of systemic lupus erythematosus |
| Q35937195 | Chlorpromazine-induced SLE |
| Q33563456 | Chronic lupus peritonitis with ascites |
| Q78179352 | Clinical and laboratory features of lupus patients with complicating pulmonary disease |
| Q39780955 | Clinical assessment of immune-complex disease in children with systemic lupus erythematosus |
| Q39737775 | Clinical immunologic studies in systemic lupus erythematosus |
| Q69170634 | Clinical neurophysiology in the assessment of neurological symptoms in systemic lupus erythematosus |
| Q70232740 | Clinical profiles of patients with antibodies to nuclear ribonucleoprotein |
| Q40908779 | Clinico-pathological diagnostic problems: fever, arthralgia and renal disease in a young woman |
| Q70219696 | Clq deposits at the dermoepidermal junction: a marker discriminating for discoid and systemic lupus erythematosus |
| Q40827014 | Cognitive changes in systemic lupus erythematosus |
| Q54423282 | Cold-reactive antinuclear IgM. Diagnostic value in a case ANA-negative lupus erythematosus. |
| Q39536979 | Comparison of chlorambucil, azathioprine or cyclophosphamide combined with corticosteroids in the treatment of lupus nephritis |
| Q80946862 | Conference report--lupus nephritis: diagnosis, therapy, and outcomes |
| Q38678826 | Connective tissue disorders and the bowel |
| Q40893656 | Constrictive pericarditis in procainamide-induced lupus erythematosus syndrome |
| Q36101807 | Contributions of renal biopsy studies to the understanding of disease |
| Q33565070 | Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus |
| Q39937928 | Corticosteroid Therapy of the Collagen Vascular Disorders |
| Q37949332 | Current treatment recommendations for lupus nephritis |
| Q38682555 | Cutaneous lesions in systemic lupus erythematosus. |
| Q36134951 | Cutaneous manifestations of systemic lupus erythematosus. |
| Q34479488 | Cutaneous small-vessel vasculitis |
| Q35086898 | Cutaneous vasculitis: a review |
| Q33569830 | Defective responsiveness to ascorbic acid of neutrophil random and chemotactic migration in Felty's syndrome and systemic lupus erythematosus |
| Q94241931 | Dermacase |
| Q38186995 | Diagnosis and management of neuropsychiatric SLE. |
| Q31166031 | Diagnosis and pathogenesis of CNS lupus |
| Q33447576 | Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks |
| Q33431990 | Differences in disease phenotype and severity in SLE across age groups |
| Q40813159 | Differential diagnosis of fever in systemic lupus erythematosus using discriminant analysis |
| Q39882238 | Diffuse Pulmonary Interstitial Disease; An Immunohistologic Study |
| Q39449781 | Diffuse lymphadenopathy as the presenting manifestation of systemic lupus erythematosus |
| Q70624757 | Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome |
| Q36146622 | Disease Expression and HLA Types in Early and Late Onset Disease of Malaysian Patients with Systemic Lupus Erythematosus |
| Q33750407 | Diversity in presenting manifestations of systemic lupus erythematosus in children |
| Q41028309 | Does corticosteroid therapy affect the survival of patients with systemic lupus erythematosus? |
| Q40119190 | Down's Syndrome: Nutritional Intervention |
| Q66835714 | Editorial: Cerebral lupus |
| Q71406876 | Effect of pregnancy in patients with lupus nephropathy |
| Q40143791 | Elevated levels of cerebrospinal fluid guanosine 3′,5′-cyclic monophosphate (C-GMP) in systemic lupus erythematosus |
| Q40868199 | End-stage renal disease in systemic lupus erythematosus |
| Q33565114 | Epidemiology of systemic lupus erythematosus |
| Q33366672 | Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt |
| Q42581650 | Ethmoid sinus carcinoma metastasising to the cauda equina: a case report |
| Q44112212 | Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: a case-control study |
| Q41077261 | Fibrinogen catabolism in systemic lupus erythematosus |
| Q46537624 | Gastrointestinal vasculitis and pneumatosis intestinalis due to systemic lupus erythematosus: successful treatment with pulse intravenous cyclophosphamide |
| Q66837294 | Glomerulonephritis |
| Q30424263 | HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD |
| Q33479816 | Hematologic forms of lupus erythematosus disseminatus with and without antinuclear factors. 25 case reports |
| Q35553844 | Hepatic manifestations of autoimmune rheumatic diseases |
| Q35225827 | High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort. |
| Q68098260 | How useful are combinations of blood tests in "rheumatic panels" in diagnosis of rheumatic diseases? |
| Q77800114 | Hypertrophic cardiomyopathy and systemic lupus erythematosus |
| Q45177766 | Idiopathic membranous glomerulopathy preceding the emergence of systemic lupus erythematosus in two children |
| Q39758006 | Immune Complex Disease in the New Zealand Black/White Hybrid Mouse Lung |
| Q39830587 | Immune complex nephropathy in mixed connective tissue disease |
| Q39563452 | Immunogenetics of SLE and primary Sjögren's syndrome |
| Q70358811 | Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus |
| Q67252364 | Immunopathology of cardiac lesions in fatal systemic lupus erythematosus |
| Q44595953 | Impairment of left ventricular diastolic function in systemic lupus erythematosus |
| Q79339706 | Improving survival in inflammatory rheumatic diseases: a neglected goal? |
| Q74600355 | Infection in systemic lupus erythematosus |
| Q39546725 | Late onset systemic lupus erythematosus |
| Q49197469 | Letter: Treatment of C.N.S. involvement in systemic lupus erythematosus |
| Q44360517 | Life-threatening extrarenal lupus in children despite improvement in serologic findings |
| Q51768694 | Lupus erythematosus (LE) cells in ascites: initial diagnosis of systemic lupus erythematosus by cytological examination: a case report. |
| Q53760871 | Lupus erythematosus: a disease of D.N.A. discard? |
| Q68125366 | Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL) |
| Q35145310 | Lupus nephritis: response to azathioprine |
| Q71709817 | Lupus peritonitis mimicking acute surgical abdomen in a patient with systemic lupus erythematosus: report of a case |
| Q40666454 | Lymphadenopathy in systemic lupus erythematosus. Prevalence and relation to disease manifestations |
| Q46909297 | Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus |
| Q52079771 | Misunderstood somatopsychic concomitants of medical disorders. |
| Q36757876 | Monoclonal IgM rheumatoid factors bind IgG at a discontinuous epitope comprised of amino acid loops from heavy-chain constant-region domains 2 and 3. |
| Q41668485 | Mortality in lupus nephritis |
| Q54544649 | Mortality in systemic lupus erythematosus: a 10-year review. |
| Q34980901 | Myocarditis in systemic lupus erythematosus |
| Q71683968 | Necrotizing lymphadenitis associated with systemic lupus erythematosus |
| Q40082544 | Necrotizing vasculitis |
| Q39644827 | Neoplastic associations of rheumatic diseases and rheumatic manifestations of cancer. |
| Q73181348 | Nephrotic syndrome associated with focal segmental glomerulosclerosis in a patient with systemic lupus erythematosus and membranous glomerulonephritis in remission |
| Q33569767 | Nervous system involvement in systemic lupus erythematosus |
| Q30667365 | Neurologic manifestations of connective tissue disease |
| Q72496029 | Neurological complications of connective tissue and other “collagen-vascular” diseases |
| Q33618889 | Neurological lupus erythematosus with tonic seizures simulating multiple sclerosis |
| Q42453499 | Neuropathological features of a lupus-like disorder in autoimmune mice |
| Q40469520 | Neuropsychiatric Manifestations of Systemic Lupus Erythematosus |
| Q34250901 | Neuropsychiatric lupus |
| Q33562378 | Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies. |
| Q43731306 | Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies |
| Q52119606 | Neuropsychiatric problems in systemic lupus erythematosus. |
| Q67337023 | On survivorship in the nephritis of systemic lupus erythematosus |
| Q44446036 | Oral mucosal ulceration in systemic lupus erythematosus |
| Q46592474 | Outcomes in African Americans and Hispanics with lupus nephritis. |
| Q39485237 | Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus |
| Q45823777 | Parkinsonism and transient bilateral ptosis in systemic lupus erythematosus. |
| Q70302563 | Pathologic differentiation between lupus and nonlupus membranous glomerulopathy |
| Q33570086 | Pericardial effusion and mitral valve involvement in systemic lupus erythematosus. Echocardiographic study |
| Q74078826 | Peripheral neuropathy in systemic lupus erythematosus--a longitudinal study |
| Q70890381 | Platelet FcIgG receptior: Increased expression in female platelets |
| Q33819726 | Pleuropulmonary manifestations of systemic lupus erythematosus |
| Q72817289 | Polyclhonal B-cell activation and increased lymphocyte helper-suppressor ratios in discoid lupus erythematosus |
| Q73251573 | Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus |
| Q57704421 | Prevalence and significance of hypertension in systemic lupus erythematosus |
| Q86527461 | Prevention of recurrent stroke in patients with systemic lupus erythematosus or lupus anticoagulant |
| Q69995152 | Prognosis and treatment of membranous nephropathy |
| Q33286668 | Prognostic factors in systemic lupus erythematosus |
| Q46085129 | Progressive Hilar and Mediastinal Lymphadenopathy in Systemic Lupus Erythematosus on Corticosteroid Therapy |
| Q41435731 | Pseudolymphoma of the lung in a patient with systemic lupus erythematosus |
| Q52112343 | Psychiatric Problems in Systemic Lupus Erythematosus |
| Q54544457 | Pulmonary hypertension in systemic lupus erythematosus: hemodynamics and effects of vasodilator therapy. |
| Q39817683 | Pulmonary manifestations of the rheumatic diseases |
| Q36999306 | Pulmonary renal syndromes--a review. |
| Q40265664 | Pulmonary renal syndromes. II. Etiology and pathogenesis |
| Q69520074 | Purpura |
| Q41641122 | Purpura in infants and children |
| Q35549094 | Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus |
| Q37146440 | Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy |
| Q33824546 | Recent advances in the immunopathogenesis of systemic lupus erythematosus |
| Q33987313 | Recent observations on central nervous system lupus erythematosus |
| Q71974829 | Recurrent peritonitis with ascites as the predominant manifestation of systemic lupus erythematosus |
| Q36269545 | Respiratory disease in systemic lupus erythematosus: correlation with results of laboratory tests and histological appearance of muscle biopsy specimens |
| Q66885995 | Respiratory involvement in systemic lupus erythematosus. A clinical and immunological study |
| Q37640958 | Review: Male systemic lupus erythematosus: a review of sex disparities in this disease |
| Q35222834 | Review: Treatment of Cutaneous Lupus Erythematosus |
| Q33608032 | Risks of endoscopy in hospitalized pediatric patients with collagen vascular diseases |
| Q40572101 | Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus |
| Q84078404 | SLE-related longitudinal myelitis with favorable outcome |
| Q43775404 | Sample stability and variability of B-cell subsets in blood from healthy subjects and patients with systemic lupus erythematosus |
| Q68170323 | Scarring alopecia |
| Q39906788 | Segregation of human peripheral blood lymphocytes according to their affinity for insolubilized histamine. Principal differences between males and females |
| Q33562546 | Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus |
| Q30499023 | Severe deafness in systemic lupus erythematosus: its immediate relief by plasma exchange |
| Q93710436 | Significance of anti-D.N.A. antibodies in systemic lupus erythematosus |
| Q33733833 | Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms |
| Q70033141 | Skin lesions, angio-oedema, and hypocomplementaemia |
| Q40663864 | Soluble deoxyribonucleoprotein (sNP) complexes in the pleural effusion of rheumatoid arthritis |
| Q77577768 | Spontaneous contractures of both abductor digiti minimi muscles in a patient with systemic lupus erythematosus |
| Q34564739 | Spontaneous immunoglobulin A secretion and lack of mitogen-responsive B cells in systemic lupus erythematosus |
| Q93722902 | Sterility and cyclophosphamide |
| Q79878050 | Systemic Lupus Erythematosus Vasculitis: A Current Therapeutic Overview |
| Q67025823 | Systemic Lupus Erythematosus in a Patient with Hashimoto's Thyroiditis and Pernicious Anaemia |
| Q36204062 | Systemic Lupus Erythematosus with Central Nervous System Involvement |
| Q36998914 | Systemic and discoid lupus erythematosus: analysis of pulmonary function. |
| Q70781020 | Systemic lupus erythematosus |
| Q43419630 | Systemic lupus erythematosus and cardiovascular disease |
| Q39756290 | Systemic lupus erythematosus clinical issues |
| Q38046207 | Systemic lupus erythematosus for general practitioners: a literature review |
| Q44834941 | Systemic lupus erythematosus in North Indian Asians. A prospective analysis of clinical and immunological features |
| Q33553002 | Systemic lupus erythematosus in childhood |
| Q78374010 | Systemic lupus erythematosus in childhood |
| Q71867653 | Systemic lupus erythematosus in patients diagnosed with treatment-resistant acne |
| Q70287507 | Systemic lupus erythematosus in patients with chronic renal failure |
| Q68918938 | Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity |
| Q73874031 | Systemic lupus erythematosus patients with respiratory symptoms: the value of HRCT |
| Q48800833 | Systemic lupus erythematosus with multiple perivascular spongy changes in the cerebral deep structures, midbrain and cerebellar white matter: a case report |
| Q33555951 | Systemic lupus erythematosus without clinical renal abnormalities: renal biopsy findings and clinical course |
| Q33564680 | Systemic lupus erythematosus--changing disease patterns in the disease course. Dutch experience with 110 patients studied prospectively |
| Q33554352 | Systemic lupus erythematosus. A prospective analysis |
| Q33561741 | Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively |
| Q33561747 | Systemic lupus erythematosus. II. Observations on the occurrence of exacerbations in the disease course: Dutch experience with 110 patients studied prospectively |
| Q41932262 | Systemic lupus erythematosus: Nephritis, dilated cardiomyopathy, and extensive cutaneous depigmentation responsive to hydroxychloroquine |
| Q51035970 | Systemic lupus erythematosus: clinical manifestations and immunological parameters in 194 patients. Subgroup classification of SLE. |
| Q33454118 | Systemic lupus erythematosus: follow-up study of 148 patients. I: Classification, clinical and laboratory findings, course and outcome |
| Q41923072 | Systemic lupus erythematosus: important considerations in the adolescent |
| Q33568505 | Testing the 'preliminary criteria for classification of SLE'. |
| Q33556000 | Tetraplegia as a presenting feature of systemic lupus erythematosus complicated by pulmonary hypertension. |
| Q70237799 | The Long-Term Clinical Course of Systemic Lupus Erythematosus in End-Stage Renal Disease |
| Q67857724 | The actual survival rate in systemic lupus erythematosus: study of a 1976 cohort |
| Q33551584 | The arthritis of mixed connective tissue disease |
| Q36722914 | The association between sequential changes in serum antineuronal antibodies and neuropsychiatric systemic lupus erythematosus |
| Q39848257 | The associations and relationships of congenital immune deficiency states and autoimmune phenomena |
| Q43703475 | The bimodal mortality pattern of systemic lupus erythematosus |
| Q48438153 | The choroid plexus in CNS involvement of systemic lupus erythematosus |
| Q67564579 | The clinical aspects of systemic lupus erythematosus |
| Q41723868 | The clinical significance of raynaud's phenomenon in systemic lupus erythematosus |
| Q33685823 | The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration |
| Q35148597 | The epidemiology of systemic lupus erythematosus |
| Q33535433 | The heart in systemic lupus erythematosus |
| Q66980031 | The neuro-ophthalmology of systemic lupus erythematosus |
| Q33551926 | The neuropsychiatric disorder in systemic lupus erythematosus: evidence for both vascular and immune mechanisms |
| Q42055183 | The pathogenesis of neuropsychiatric lupus |
| Q36715090 | The treatment of lupus nephritis by methyl prednisolone pulse therapy |
| Q34731092 | Therapy of systemic lupus erythematosus: a look into the future |
| Q40734777 | Thiamphenicol as an Immunosuppressant in Active Systemic Lupus Erythematosus with Nephritis |
| Q38807549 | Toll-like receptor 7-stimulated tumor necrosis factor α causes bone marrow damage in systemic lupus erythematosus |
| Q39445188 | Transverse myelitis with systemic lupus erythematosus |
| Q33621877 | Treatment of acute myelopathy in systemic lupus erythematosus with plasma exchange and immunosuppression |
| Q28363829 | Treatment of patients with systemic lupus erythematosus including nephritis with chlorambucil |
| Q33552323 | Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus |
| Q43659943 | Variables associated with decreased survival in systemic lupus erythematosus |
| Q39701514 | Vasculitis and ulceration in rheumatic diseases of the foot |
| Q40089640 | Vasculitis in primary vasculitides, granulomatoses, and connective tissue diseases |
| Q36203966 | Visual, Somatosensory, Olfactory, and Gustatory Hallucinations |
| Q34484053 | Why do patients with lupus nephritis die? |
| Q80146676 | Why rheumatologists should be involved in the treatment of lupus nephritis |
| Q67823941 | [Pleuropulmonary manifestations of systemic lupus erythematosus] |
| Q68138012 | [Pulmonary arterial hypertension and systemic lupus erythematosus. Apropos of 2 cases. Review of the literature] |
Search more.